Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy
Author:
Publisher
Elsevier BV
Subject
Virology
Reference25 articles.
1. Improved Cobas TaqMan hepatitis C virus test (version 2.0) for use with the high pure system: enhanced genotype inclusivity and performance characteristics in a multisite study;Colucci;J. Clin. Microbiol.,2007
2. EASL Clinical Practice Guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver;J. Hepatol.,2011
3. Faldaprevir plus pegylated Interferon alfa-2a and ribavirin in chronic HCV genotype-1 treatment-naive patients: final results from Startverso1, a randomised, double-blind, placebo-controlle phase III trial;Ferenci;J. Hepatol.,2013
4. Hepatitis C virus RNA quantification with different assays: implications for protease inhibitor-based response guided therapy;Fevery;Antivir Ther.,2014
5. Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor Ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection;Gane;Gastroenterology,2014
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?;Antiviral Research;2023-12
2. Safety and efficacy of grazoprevir/elbasvir in the treatment of acute hepatitis C in hemodialysis patients;Journal of Medical Virology;2021-10-18
3. Novel SARS-CoV-2 encoded small RNAs in the passage to humans;Bioinformatics;2020-11-27
4. Effect of Low Positive End of Treatment Viral Load with Direct-Acting Antiviral Therapy on Sustained Virologic Response;Canadian Journal of Gastroenterology and Hepatology;2020-07-27
5. Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy;The Journal of Infectious Diseases;2020-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3